Sunday, August 1, 2021

Pharma sales grow 51% in April: AIOCD AWACS – ET HealthWorld

Sales of medicines by top pharma companies across India witnessed a robust growth of 51.5% in April. The growth was further fuelled by robust sales of drugs used — directly and indirectly — in the treatment of Covid-19, stated AIOCD AWACS, a pharma market research firm.

The overall drug sales in the domestic market jumped at Rs 15,662 crore in April as compared to Rs 10,337 crore in the same month last year.

Covid second wave has further boosted the sales of drugs having direct or indirect role in treatment. Companies operating in Covid treatment therapy segments have gained substantially through bumper sales for the month,” the research further added in its monthly update.

The industry players, however, also maintained that the growth rate looks higher because the overall sales were very low in April last year on account of the nationwide lockdown in that month.

Follow and connect with us on , Facebook, Linkedin

Source link

Stay Connected


Latest Articles

Need to create vigilance and awareness on zoonotic diseases: India’s Health Minister

The COVID-19 pandemic has highlighted the need of creating vigilance and awareness on zoonotic diseases, informed Union Health Minister Mansukh Mandaviya while virtually inaugurating...

Covid’s second wave proves lethal for pregnant women

At SVP Hospital in Ahmedabad – one of the major Covid-19 hospitals of the city – 148 pregnant women with Covid-19 infection were admitted...

7 Tips to Keep Your Gut Healthy

This is common to say health (and illness) starts in your gut. If you have poor gut health, you’ll experience anything from wrinkled skin, to...

SII making first batch of Covovax: Poonawalla

The first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India's Pune facility, SII...

Sputnik V is safest among all Covid-19 vaccines, no deaths recorded: Buenos Aires study

A study by the Buenos Aires Ministry of Health to monitor the safety of the Sputnik V vaccine against Covid-19 confirmed on Thursday that...